PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $47,000 | -44.7% | 21,796 | -32.3% | 0.00% | -20.0% |
| Q3 2018 | $85,000 | +174.2% | 32,213 | +146.4% | 0.01% | +400.0% |
| Q2 2018 | $31,000 | +3.3% | 13,072 | +17.6% | 0.00% | -50.0% |
| Q4 2017 | $30,000 | -79.6% | 11,114 | -74.4% | 0.00% | -71.4% |
| Q3 2017 | $147,000 | -33.5% | 43,434 | +26.4% | 0.01% | -65.0% |
| Q2 2015 | $221,000 | – | 34,355 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |